BMJ Open (Mar 2023)

Can we design the next generation of digital health communication programs by leveraging the power of artificial intelligence to segment target audiences, bolster impact and deliver differentiated services? A machine learning analysis of survey data from rural India

  • Amnesty Elizabeth LeFevre,
  • Kerry Scott,
  • Nicola Mulder,
  • Jean Juste Harrisson Bashingwa,
  • Diwakar Mohan,
  • Sara Chamberlain,
  • Osama Ummer,
  • Anna Godfrey,
  • Deshendran Moodley

DOI
https://doi.org/10.1136/bmjopen-2022-063354
Journal volume & issue
Vol. 13, no. 3

Abstract

Read online

Objectives Direct to beneficiary (D2B) mobile health communication programmes have been used to provide reproductive, maternal, neonatal and child health information to women and their families in a number of countries globally. Programmes to date have provided the same content, at the same frequency, using the same channel to large beneficiary populations. This manuscript presents a proof of concept approach that uses machine learning to segment populations of women with access to phones and their husbands into distinct clusters to support differential digital programme design and delivery.Setting Data used in this study were drawn from cross-sectional survey conducted in four districts of Madhya Pradesh, India.Participants Study participant included pregnant women with access to a phone (n=5095) and their husbands (n=3842)Results We used an iterative process involving K-Means clustering and Lasso regression to segment couples into three distinct clusters. Cluster 1 (n=1408) tended to be poorer, less educated men and women, with low levels of digital access and skills. Cluster 2 (n=666) had a mid-level of digital access and skills among men but not women. Cluster 3 (n=1410) had high digital access and skill among men and moderate access and skills among women. Exposure to the D2B programme ‘Kilkari’ showed the greatest difference in Cluster 2, including an 8% difference in use of reversible modern contraceptives, 7% in child immunisation at 10 weeks, 3% in child immunisation at 9 months and 4% in the timeliness of immunisation at 10 weeks and 9 months.Conclusions Findings suggest that segmenting populations into distinct clusters for differentiated programme design and delivery may serve to improve reach and impact.Trial registration number NCT03576157.